Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho.
about
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringRates of switching antiretroviral drugs in a primary care service in South Africa before and after introduction of tenofovirEvaluation of the Nova StatSensor® Xpress(TM) Creatinine point-of-care handheld analyzerEffect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia.Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection.Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.Low Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar.The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women.Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort.HIV treatment and care in resource-constrained environments: challenges for the next decade.Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimensMulti-Media Educational Tool Increases Knowledge of Clinical Trials in Uganda.Update on tenofovir toxicity in the kidney.Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.The incidence of first-line antiretroviral treatment changes and related factors among HIV-infected sex workers in Nairobi, Kenya.Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.Associations between plasma tenofovir concentration and renal function markers in HIV-infected women.
P2860
Q28482138-212C23D6-9471-4911-9661-369065DB74CBQ28533242-A045B8A7-1B6E-418A-96A9-30DAB9A20CE5Q28546520-527F4C6D-8429-4580-B939-867CBF301FDAQ31108490-7414CCB5-DBA6-4A77-A6DC-80DE377E9E1CQ34126724-32151F0F-116C-41B4-98E4-7AEDD86869A7Q34174009-FCF52AB6-EEEB-42B5-9084-35F311D3C4E3Q34536677-63CC4D84-51D9-443B-9D24-8E20595AB757Q34736194-386CE8FE-A872-48B1-9CE7-8D40E9C915C5Q35107651-4BD0DE62-4659-4639-A23E-6C5EB50949ECQ35753540-51971F75-7012-4FA7-8A94-B27574C770CFQ35906897-BEF40053-8EFD-4A50-BD9C-92F25F15767EQ36106860-1A9B2B4E-691D-4E28-A832-DD1956B6A9EFQ36237157-D0AC4CFD-9A83-4819-BE3F-96B6981D5FE7Q36386806-369C9981-04B2-4E33-914D-B57E26A68D43Q36993353-371927DD-E85E-4630-85B6-FA44ACD185C6Q37263602-99627C2E-1E42-46BE-8E60-EBBEDCA1AB28Q37732896-48432F9A-E3F8-4C2D-8F4D-C02CF3254051Q38033446-B6D0CB61-4ACB-4A8C-9081-AED79EF9B0A2Q40244089-2399E9EF-E84C-4DE3-9AF0-E960636F04AFQ41639431-23A42191-2EA5-4E3D-B540-5F8416803ECCQ46760752-9A1A6367-AEFC-43F8-A2B8-A8F7DFFCFE18Q47553173-DBDBEE7C-4854-4E0A-AB47-22F9F3C28732Q53756185-7C78E47D-4280-47FA-9C4A-828897953FB2
P2860
Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@ast
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@en
type
label
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@ast
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@en
prefLabel
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@ast
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@en
P2093
P2860
P1433
P1476
Renal safety of a tenofovir-co ...... viral cohort in rural Lesotho.
@en
P2093
Eric Goemaere
Guillaume Jouquet
Helen Bygrave
Katharina Kranzer
Katherine Hilderbrand
Laura Triviño
Lipontso Makakole
Nathalie Vlahakis
Nathan Ford
P2860
P304
P356
10.1371/JOURNAL.PONE.0017609
P407
P577
2011-03-02T00:00:00Z